Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV4 | Q9HBA0 | 19/20 | 1.00 |
| ▸ | TACR2 | P21452 | 2/20 | 0.64 |
| ▸ | TACR3 | P29371 | 2/20 | 0.64 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.64 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.64 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.64 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2400335 | 0.96 | TRPV4 (0.92) | TRPV4TACR2TACR3KCNH2CACNA1C | |
| SCHEMBL2371586 | 0.93 | TRPV4 (0.88) | TRPV4TACR2TACR3KCNH2CACNA1C | |
| SCHEMBL6845630 | 0.93 | TRPV4 (1.00) | TRPV4TACR2TACR3KCNH2CACNA1C | |
| SCHEMBL2387514 | 0.92 | TRPV4 (0.99) | TRPV4TACR2TACR3KCNH2CACNA1C | |
| SCHEMBL25209401 | 0.91 | TRPV4 (0.90) | TRPV4TACR2TACR3KCNH2CACNA1C | |
| SCHEMBL6845465 | 0.91 | TRPV4 (0.85) | TRPV4TACR2TACR3KCNH2CACNA1C | |
| SCHEMBL6870097 | 0.91 | TRPV4 (0.83) | TRPV4TACR2TACR3KCNH2CACNA1C | |
| SCHEMBL6845631 | 0.90 | TRPV4 (1.00) | TRPV4TACR2TACR3KCNH2CACNA1C | |
| SCHEMBL2401714 | 0.90 | TRPV4 (0.88) | TRPV4TACR2TACR3KCNH2CACNA1C | |
| SCHEMBL6845669 | 0.90 | TRPV4 (0.83) | TRPV4TACR2TACR3KCNH2CACNA1C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 85 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250352615-A1 | COMPOSITIONS AND METHODS FOR THE MODULATION OF PIEZO1 AND TRPV4 | UNIV DUKE (US) | 2025-11-20 | — | — | US | claimed |
| WO-2025096549-A1 | COMPOUNDS AND METHODS FOR THE TREATMENT OF BRAIN INJURIES | OHIO STATE INNOVATION FOUNDATION (US) | 2025-05-08 | — | — | WO | claimed |
| WO-2025051930-A1 | PHARMACEUTICAL COMPOSITION COMPRISING TRPV4 INHIBITOR FOR USE IN THE PREVENTION OR TREATMENT OF CEREBRAL CAVERNOUS MALFORMATIONS (CCM) | UNIVERSITE GRENOBLE ALPES (FR) | 2025-03-13 | — | — | WO | claimed |
| EP-4520331-A1 | PHARMACEUTICAL COMPOSITION COMPRISING TRPV4 INHIBITOR FOR USE IN THE PREVENTION OR TREATMENT OF CEREBRAL CAVERNOUS MALFORMATIONS (CCM) | Université Grenoble Alpes (FR) | 2025-03-12 | — | — | EP | claimed |
| WO-2025029629-A2 | TRPV4 INHIBITION TO TREAT ARRHYTHMIC CARDIOMYOPATHY | DUKE UNIVERSITY (US) | 2025-02-06 | — | — | WO | claimed |
| WO-2024217445-A1 | USE OF TRPV4 INHIBITOR IN TREATMENT OF CHRONIC HEPATITIS B, HEPATIC FIBROSIS, AND LIVER CANCER | 河北乌图药业有限公司 | 2024-10-24 | — | — | WO | claimed |
| WO-2024216180-A1 | TARGETING THE PANX1–P2Y2R–TRPV4 PATHWAY TO TREAT LUNG ISCHEMIA-REPERFUSION INJURY | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2024-10-17 | — | — | WO | claimed |
| EP-3585371-B1 | METHODS OF INHIBITING SERUM GLUCOCORTICOID INDUCED KINASE 1 (SGK1) AS A TREATMENT FOR SALT AND WATER BALANCE DISEASES | UNIV INDIANA RES & TECH CORP (US) | 2024-07-10 | — | — | EP | claimed |
| CN-117205319-A | Application of TRPA1 ion channel as drug target in paraquat poisoning | 中国人民解放军军事科学院军事医学研究院 | 2023-12-12 | — | — | CN | claimed |
| CN-116814528-A | Culture medium, polycystic kidney organoid culture method and application | 山东大学 | 2023-09-29 | — | — | CN | claimed |
| CN-116726013-A | Application of GSK2193874 in preventing and treating painful diabetic peripheral neuropathy | 中国科学院大学深圳医院(光明) | 2023-09-12 | — | — | CN | claimed |
| US-20230255965-A1 | TRPV4 INHIBITOR AS A THERAPEUTIC AGENT FOR OCULAR DISEASES | RAQUALIA PHARMA INC. (JP) | 2023-08-17 | — | — | US | claimed |
| CN-116510017-A | Application of TRPV4 inhibitor in treatment of chronic hepatitis B, liver fibrosis and liver cancer | 河北乌图药业有限公司 | 2023-08-01 | — | — | CN | claimed |
| US-11701358-B2 | Methods of inhibiting serum glucocorticoid induced kinase 1 (SGKI) as a treatment for salt and water balance diseases | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2023-07-18 | — | — | US | claimed |
| WO-2023091901-A1 | COMPOSITIONS AND METHODS FOR THE MODULATION OF PIEZO1 AND TRPV4 | DUKE UNIVERSITY (US) | 2023-05-25 | — | — | WO | claimed |
| EP-4183415-A1 | TRPV4 INHIBITOR AS THERAPEUTIC DRUG FOR EYE DISEASE | RaQualia Pharma Inc. (JP) | 2023-05-24 | — | — | EP | claimed |
| CN-115776890-A | TRPV4 inhibitors as therapeutic agents for eye diseases | 拉夸里亚创药株式会社 | 2023-03-10 | — | — | CN | claimed |
| US-11318140-B2 | Use of TRPV4 antagonists to ameliorate hydrocephalus and related materials and methods | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2022-05-03 | — | — | US | claimed |
| US-11058707-B2 | Methods for treating ischemic heart disease by targeting TRPV4 | NORTHEAST OHIO MEDICAL UNIVERSITY (US) | 2021-07-13 | — | — | US | claimed |
| US-12582649-B2 | Compositions and methods for hair follicle regeneration | WASHINGTON UNIVERSITY (US) | 2026-03-24 | — | — | US | disclosed |
| US-20260048098-A1 | TREATMENT OF RETINAL GANGLION CELL LOSS | PS THERAPY INC (US) | 2026-02-19 | — | — | US | disclosed |
| US-12552773-B2 | Compound for specifically enhancing spatial coupling degree of TRPV4-KCa2.3 complex and use thereof | JIANGNAN UNIVERSITY (CN) | 2026-02-17 | — | — | US | disclosed |
| US-20250352615-A1 | COMPOSITIONS AND METHODS FOR THE MODULATION OF PIEZO1 AND TRPV4 | UNIV DUKE (US) | 2025-11-20 | — | — | US | disclosed |
| CN-120536343-A | Method for constructing polycystic kidney disease model and application of polycystic kidney disease model in drug screening | 山东大学 | 2025-08-26 | — | — | CN | disclosed |
| CN-116814528-B | Culture medium, polycystic kidney organoid culture method and application | 山东大学 | 2025-06-17 | — | — | CN | disclosed |
| CN-116814528-B | Culture medium, polycystic kidney organoid culture method and application | 山东大学 | 2025-06-17 | — | — | CN | disclosed |
| WO-2025096549-A1 | COMPOUNDS AND METHODS FOR THE TREATMENT OF BRAIN INJURIES | OHIO STATE INNOVATION FOUNDATION (US) | 2025-05-08 | — | — | WO | disclosed |
| CN-119757270-A | Medicinal material quality grade evaluation method for near infrared rapid detection of content of calcium antagonism efficacy component in magnolia officinalis | 广西中医药大学 | 2025-04-04 | — | — | CN | disclosed |
| WO-2025051930-A1 | PHARMACEUTICAL COMPOSITION COMPRISING TRPV4 INHIBITOR FOR USE IN THE PREVENTION OR TREATMENT OF CEREBRAL CAVERNOUS MALFORMATIONS (CCM) | UNIVERSITE GRENOBLE ALPES (FR) | 2025-03-13 | — | — | WO | disclosed |
| EP-4520331-A1 | PHARMACEUTICAL COMPOSITION COMPRISING TRPV4 INHIBITOR FOR USE IN THE PREVENTION OR TREATMENT OF CEREBRAL CAVERNOUS MALFORMATIONS (CCM) | Université Grenoble Alpes (FR) | 2025-03-12 | — | — | EP | disclosed |
| WO-2025029629-A2 | TRPV4 INHIBITION TO TREAT ARRHYTHMIC CARDIOMYOPATHY | DUKE UNIVERSITY (US) | 2025-02-06 | — | — | WO | disclosed |
| US-20240385177-A1 | Screening Method Using Brown Adipocytes | KATAOKA CORPORATION (JP) | 2024-11-21 | — | — | US | disclosed |
| WO-2024217445-A1 | USE OF TRPV4 INHIBITOR IN TREATMENT OF CHRONIC HEPATITIS B, HEPATIC FIBROSIS, AND LIVER CANCER | 河北乌图药业有限公司 | 2024-10-24 | — | — | WO | disclosed |
| WO-2024216180-A1 | TARGETING THE PANX1–P2Y2R–TRPV4 PATHWAY TO TREAT LUNG ISCHEMIA-REPERFUSION INJURY | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2024-10-17 | — | — | WO | disclosed |
| CN-118389488-B | Temperature-sensitive TRPS ion channel-mediated activation type microwave nerve regulation technology and application thereof | 中国人民解放军军事科学院军事医学研究院 | 2024-10-11 | — | — | CN | disclosed |
| US-20240326041-A1 | MICROFLUIDIC INDUCTION OF RESEARCH BASED NEURAL INJURY | WORCESTER POLYTECH INST (US) | 2024-10-03 | — | — | US | disclosed |
| WO-2024206784-A1 | MICROFLUIDIC INDUCTION OF RESEARCH BASED NEURAL INJURY | WORCESTER POLYTECHNIC INSTITUTE (US) | 2024-10-03 | — | — | WO | disclosed |
| CN-117205319-B | Application of HC030031 in preparation of medicine for preventing or treating lung injury caused by paraquat poisoning | 中国人民解放军军事科学院军事医学研究院 | 2024-09-03 | — | — | CN | disclosed |
| EP-4407040-A1 | SCREENING METHOD USING BROWN ADIPOCYTES | Kataoka Corporation (JP) | 2024-07-31 | — | — | EP | disclosed |
| US-12048750-B2 | Tissue-homing peptide conjugates and methods of use thereof | Blaze Bioscience, Inc. (US) | 2024-07-30 | — | — | US | disclosed |
| CN-118389488-A | Temperature-sensitive TRPS ion channel-mediated activation type microwave nerve regulation technology and application thereof | 中国人民解放军军事科学院军事医学研究院 | 2024-07-26 | — | — | CN | disclosed |
| EP-3585371-B1 | METHODS OF INHIBITING SERUM GLUCOCORTICOID INDUCED KINASE 1 (SGK1) AS A TREATMENT FOR SALT AND WATER BALANCE DISEASES | UNIV INDIANA RES & TECH CORP (US) | 2024-07-10 | — | — | EP | disclosed |
| US-12013398-B2 | Compositions and methods for treatment of invasive cancers | THE GEORGE WASHINGTON UNIVERSITY (US) | 2024-06-18 | — | — | US | disclosed |
| CN-117388500-B | Application of TRPV4 as drug target in coronavirus infection anti-inflammatory drug | 暨南大学 | 2024-06-04 | — | — | CN | disclosed |
| US-11883344-B2 | Neural stimulation in vitro and in vivo by photoacoustic nanotransducers | TRUSTEES OF BOSTON UNIVERSITY (US) | 2024-01-30 | — | — | US | disclosed |
| CN-117388500-A | Application of TRPV4 as drug target in coronavirus infection anti-inflammatory drug | 暨南大学 | 2024-01-12 | — | — | CN | disclosed |
| US-20240002437-A1 | COMPOSITIONS AND METHODS OF TREATING INFLAMMATORY LUNG DISEASES | NATIONAL INSTITUTES OF HEALTH | 2024-01-04 | — | — | US | disclosed |
| CN-117205319-A | Application of TRPA1 ion channel as drug target in paraquat poisoning | 中国人民解放军军事科学院军事医学研究院 | 2023-12-12 | — | — | CN | disclosed |
| US-11773445-B1 | Diagnostic methods | GRIFFITH UNIVERSITY | 2023-10-03 | — | — | US | disclosed |
| CN-116814528-A | Culture medium, polycystic kidney organoid culture method and application | 山东大学 | 2023-09-29 | — | — | CN | disclosed |
| CN-116814528-A | Culture medium, polycystic kidney organoid culture method and application | 山东大学 | 2023-09-29 | — | — | CN | disclosed |
| CN-116726013-A | Application of GSK2193874 in preventing and treating painful diabetic peripheral neuropathy | 中国科学院大学深圳医院(光明) | 2023-09-12 | — | — | CN | disclosed |
| CN-116726013-A | Application of GSK2193874 in preventing and treating painful diabetic peripheral neuropathy | 中国科学院大学深圳医院(光明) | 2023-09-12 | — | — | CN | disclosed |
| CN-116726013-A | Application of GSK2193874 in preventing and treating painful diabetic peripheral neuropathy | 中国科学院大学深圳医院(光明) | 2023-09-12 | — | — | CN | disclosed |
| US-20230277528-A1 | COMPOSITIONS AND METHODS FOR HAIR FOLLICLE REGENERATION | WASHINGTON UNIVERSITY (US) | 2023-09-07 | — | — | US | disclosed |
| US-20230255965-A1 | TRPV4 INHIBITOR AS A THERAPEUTIC AGENT FOR OCULAR DISEASES | RAQUALIA PHARMA INC. (JP) | 2023-08-17 | — | — | US | disclosed |
| WO-2023150077-A1 | NEURAL STIMULATION IN VITRO AND IN VIVO BY PHOTOACOUSTIC NANOTRANSDUCERS | TRUSTEES OF BOSTON UNIVERSITY (US) | 2023-08-10 | — | — | WO | disclosed |
| US-20230240935-A1 | NEURAL STIMULATION IN VITRO AND IN VIVO BY PHOTOACOUSTIC NANOTRANSDUCERS | TRUSTEES OF BOSTON UNIVERSITY (US) | 2023-08-03 | — | — | US | disclosed |
| CN-116510017-A | Application of TRPV4 inhibitor in treatment of chronic hepatitis B, liver fibrosis and liver cancer | 河北乌图药业有限公司 | 2023-08-01 | — | — | CN | disclosed |
| US-11701358-B2 | Methods of inhibiting serum glucocorticoid induced kinase 1 (SGKI) as a treatment for salt and water balance diseases | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2023-07-18 | — | — | US | disclosed |
| US-20230211000-A1 | TISSUE-HOMING PEPTIDE CONJUGATES AND METHODS OF USE THEREOF | Blaze Bioscience, Inc. | 2023-07-06 | — | — | US | disclosed |
| WO-2023091901-A1 | COMPOSITIONS AND METHODS FOR THE MODULATION OF PIEZO1 AND TRPV4 | DUKE UNIVERSITY (US) | 2023-05-25 | — | — | WO | disclosed |
| WO-2023091901-A1 | COMPOSITIONS AND METHODS FOR THE MODULATION OF PIEZO1 AND TRPV4 | DUKE UNIVERSITY (US) | 2023-05-25 | — | — | WO | disclosed |
| EP-4183415-A1 | TRPV4 INHIBITOR AS THERAPEUTIC DRUG FOR EYE DISEASE | RaQualia Pharma Inc. (JP) | 2023-05-24 | — | — | EP | disclosed |
| WO-2023048060-A1 | SCREENING METHOD USING BROWN ADIPOCYTES | 株式会社片岡製作所 | 2023-03-30 | — | — | WO | disclosed |
| CN-115776890-A | TRPV4 inhibitors as therapeutic agents for eye diseases | 拉夸里亚创药株式会社 | 2023-03-10 | — | — | CN | disclosed |
| US-11559580-B1 | Tissue-homing peptide conjugates and methods of use thereof | Blaze Bioscience, Inc. (US) | 2023-01-24 | — | — | US | disclosed |
| US-20220341937-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF INVASIVE CANCERS | THE GEORGE WASHINGTON UNIVERSITY | 2022-10-27 | — | — | US | disclosed |
| WO-2022226038-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF INVASIVE CANCERS | THE GEORGE WASHINGTON UNIVERSITY (US) | 2022-10-27 | — | — | WO | disclosed |
| US-20220305088-A1 | METHODS AND COMPOSITIONS FOR TREATING A MICROBIAL INFECTION | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2022-09-29 | — | — | US | disclosed |
| US-20220273608-A1 | Methods for Treating Bone-Related Disorders | UNIVERSITY OF MARYLAND, BALTIMORE (US) | 2022-09-01 | — | — | US | disclosed |
| US-11400136-B2 | Methods and compositions for treating a microbial infection | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2022-08-02 | — | — | US | disclosed |
| US-11331393-B2 | Renal-homing peptide conjugates and methods of use thereof | Blaze Bioscience, Inc. (US) | 2022-05-17 | — | — | US | disclosed |
| US-20220144804-A1 | Compound for Specifically Enhancing Spatial Coupling Degree of TRPV4-KCa2.3 Complex and Use thereof | JIANGNAN UNIVERSITY (CN) | 2022-05-12 | — | — | US | disclosed |
| WO-2022095461-A1 | COMPOUND FOR SPECIFICALLY ENHANCING SPATIAL COUPLING DEGREE OF TRPV4-KCA2.3 COMPLEX AND USE THEREOF | 江南大学 | 2022-05-12 | — | — | WO | disclosed |
| WO-2022093684-A1 | COMPOSITIONS AND METHODS OF TREATING INFLAMMATORY LUNG DISEASES | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2022-05-05 | — | — | WO | disclosed |
| US-11318140-B2 | Use of TRPV4 antagonists to ameliorate hydrocephalus and related materials and methods | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2022-05-03 | — | — | US | disclosed |
| US-11241442-B2 | Methods of use for TRP channel antagonist-based combination cancer therapies | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2022-02-08 | — | — | US | disclosed |
| CN-113975376-A | Application method of nanoparticle-based targeted Piezo1 protein in acute lung injury | 苏州大学附属第一医院 | 2022-01-28 | — | — | CN | disclosed |
| US-20210311075-A1 | METHODS FOR DETECTING DISORDERS RELATED TO CALCIUM DISCHARGE FROM INTRACELLULAR STORES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2021-10-07 | — | — | US | disclosed |
| US-11058707-B2 | Methods for treating ischemic heart disease by targeting TRPV4 | NORTHEAST OHIO MEDICAL UNIVERSITY (US) | 2021-07-13 | — | — | US | disclosed |
| US-20210128581-A1 | METHODS OF USE FOR TRP CHANNEL ANTAGONIST-BASED COMBINATION CANCER THERAPIES | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2021-05-06 | — | — | US | disclosed |
| US-20180280562-A1 | Fibrous Structures Comprising Sensates | THE PROCTER & GAMBLE COMPANY | 2018-10-04 | — | — | US | disclosed |
| WO-2011119704-A1 | TRPV4 ANTAGONISTS | GLAXOSMITHKLINE LLC (US) | 2011-09-29 | — | — | WO | disclosed |
| WO-2011119704-A1 | TRPV4 ANTAGONISTS | GLAXOSMITHKLINE LLC (US) | 2011-09-29 | — | — | WO | disclosed |
| WO-2011119704-A1 | TRPV4 ANTAGONISTS | GLAXOSMITHKLINE LLC (US) | 2011-09-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (12 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12048750-B2 | Tissue-homing peptide conjugates and methods of use thereof | CXCL12, CCL2, CD44 | TRPV4 3445/4885TACR2 346/4885TACR3 420/4885 |
| US-20220144804-A1 | Compound for Specifically Enhancing Spatial Coupling Degree of TRPV4-KCa2.3 Complex and Use thereof | TRPV4, TRPV2, TRPV3 | TRPV4 1/4885TACR2 437/4885TACR3 999/4885 |
| US-12552773-B2 | Compound for specifically enhancing spatial coupling degree of TRPV4-KCa2.3 complex and use thereof | TRPV4, TRPV2, TRPV6 | TRPV4 1/4885TACR2 446/4885TACR3 1443/4885 |
| US-20230277528-A1 | COMPOSITIONS AND METHODS FOR HAIR FOLLICLE REGENERATION | TRPV4, TRPC4, S100A4 | TRPV4 1/4885TACR2 248/4885TACR3 326/4885 |
| US-20260048098-A1 | TREATMENT OF RETINAL GANGLION CELL LOSS | TRPV4, TRPV3, TRPV5 | TRPV4 1/4885TACR2 189/4885TACR3 305/4885 |
| US-11331393-B2 | Renal-homing peptide conjugates and methods of use thereof | CXCL12, ATP6V1B1, VIP | TRPV4 4181/4885TACR2 219/4885TACR3 270/4885 |
| US-20230211000-A1 | TISSUE-HOMING PEPTIDE CONJUGATES AND METHODS OF USE THEREOF | CXCL12, CCL2, CD44 | TRPV4 3445/4885TACR2 346/4885TACR3 420/4885 |
| US-11701358-B2 | Methods of inhibiting serum glucocorticoid induced kinase 1 (SGKI) as a treatment for salt and water balance diseases | SGK1, SGK3, SGK2 | TRPV4 1665/4885TACR2 356/4885TACR3 1480/4885 |
| US-11559580-B1 | Tissue-homing peptide conjugates and methods of use thereof | CXCL12, CCL2, CD44 | TRPV4 3445/4885TACR2 346/4885TACR3 420/4885 |
| US-20250352615-A1 | COMPOSITIONS AND METHODS FOR THE MODULATION OF PIEZO1 AND TRPV4 | PIEZO1, PLA2G4A, TRPV4 | TRPV4 3/4885TACR2 1320/4885TACR3 1771/4885 |
| US-20230255965-A1 | TRPV4 INHIBITOR AS A THERAPEUTIC AGENT FOR OCULAR DISEASES | TRPV4, TRPV5, TRPV2 | TRPV4 1/4885TACR2 314/4885TACR3 885/4885 |
| US-12582649-B2 | Compositions and methods for hair follicle regeneration | TRPV4, TRPV6, TRPM4 | TRPV4 1/4885TACR2 870/4885TACR3 1521/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.